Fifth Third Bancorp
ARQT icon

Fifth Third Bancorp’s Arcutis Biotherapeutics ARQT Stock Holding History

Fifth Third Bancorp’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.22K Sell
352
-65
-16% -$1.51K ﹤0.01% 3768
2026
Q1 		$9.82K Buy
+417
New +$10.6K ﹤0.01% 3703

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fifth Third Bancorp's ARQT Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Arcutis Biotherapeutics (ARQT) stake by 16% in Q2 2026, selling an estimated $1.51K and leaving 352 shares worth $9.22K. The position accounts for ﹤0.01% of the portfolio, ranked #3768.

Fifth Third Bancorp first reported a position in ARQT in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.82K in Q1 2026. 273 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Fifth Third Bancorp held 352 shares of Arcutis Biotherapeutics worth $9.22K as of Q2 2026.
  • Fifth Third Bancorp sold 65 Arcutis Biotherapeutics shares in Q2 2026, an estimated $1.51K.
  • Arcutis Biotherapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3768 holding.
  • Fifth Third Bancorp first reported a position in Arcutis Biotherapeutics in Q1 2026 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Arcutis Biotherapeutics position peaked at $9.82K in Q1 2026.
  • 273 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.